Bleakley Financial Group LLC lifted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 30.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 41,691 ...
Maravai Lifesciences Holdings Inc (MRVI) stock has reached a new 52-week low, touching down at $4.19, representing a steep 64% decline from its 52-week high of $11.55. The $1.09 billion market cap ...
In a report released today, Brandon Couillard from Wells Fargo maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research ...
Greenwich LifeSciences, Inc.'s main program, GLSI-100, faces challenges in proving its benefit over existing HER2-positive breast cancer treatments, with ongoing phase 3 trial results expected by ...
TriLink BioTechnologies (TriLink), a Maravai LifeSciences company and global provider of life science reagents and services, has signed a non-exclusive license and supply agreement with Aldevron, a ...